Oral Semaglutide 7 mg and 14 mg Doses Showed Superior Reductio...
NEW ORLEANS, LA., Mar. 24, 2019, /PRNewswire-AsiaNet/-- Oral semaglutide 7 mg and 14 mg demonstrated superior HbA1c and body weight reductions compared to Januvia(R) (sitagliptin 100 mg). Non-inferiority for oral semaglutide 3 mg for HbA1c reductions at 26 weeks was not confirmed. Presented today at th...
Authors: LATEST ASIANET NEWS RELEASES